
Nancy J. Leith
Examiner (ID: 12198, Phone: (313)446-4874 , Office: P/1636 )
| Most Active Art Unit | 1636 |
| Art Unit(s) | 1636, 1811, 1815, 1941, 1805 |
| Total Applications | 1445 |
| Issued Applications | 999 |
| Pending Applications | 194 |
| Abandoned Applications | 284 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10554964
[patent_doc_number] => 09279162
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-03-08
[patent_title] => 'Bacteria and the uses thereof'
[patent_app_type] => utility
[patent_app_number] => 13/600596
[patent_app_country] => US
[patent_app_date] => 2012-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 11625
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13600596
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/600596 | Bacteria and the uses thereof | Aug 30, 2012 | Issued |
Array
(
[id] => 11844847
[patent_doc_number] => 09732392
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-08-15
[patent_title] => 'Modular sensor architecture for cell based biosensors'
[patent_app_type] => utility
[patent_app_number] => 14/236974
[patent_app_country] => US
[patent_app_date] => 2012-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 12122
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14236974
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/236974 | Modular sensor architecture for cell based biosensors | Aug 2, 2012 | Issued |
Array
(
[id] => 11198606
[patent_doc_number] => 09428809
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-08-30
[patent_title] => 'Solid-phase carrier for aminated oligonucleotide'
[patent_app_type] => utility
[patent_app_number] => 14/238351
[patent_app_country] => US
[patent_app_date] => 2012-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 23362
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14238351
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/238351 | Solid-phase carrier for aminated oligonucleotide | Jul 30, 2012 | Issued |
Array
(
[id] => 8637539
[patent_doc_number] => 20130029342
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-01-31
[patent_title] => 'GLYCINE RIBOSWITCHES, METHODS FOR THEIR USE, AND COMPOSITIONS FOR USE WITH GLYCINE RIBOSWITCHES'
[patent_app_type] => utility
[patent_app_number] => 13/563407
[patent_app_country] => US
[patent_app_date] => 2012-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 52
[patent_figures_cnt] => 52
[patent_no_of_words] => 35638
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13563407
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/563407 | GLYCINE RIBOSWITCHES, METHODS FOR THEIR USE, AND COMPOSITIONS FOR USE WITH GLYCINE RIBOSWITCHES | Jul 30, 2012 | Abandoned |
Array
(
[id] => 10953883
[patent_doc_number] => 20140356904
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-12-04
[patent_title] => 'BACULOVIRUS EXPRESSION SYSTEMS'
[patent_app_type] => utility
[patent_app_number] => 14/234949
[patent_app_country] => US
[patent_app_date] => 2012-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6316
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14234949
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/234949 | Baculovirus expression systems | Jul 26, 2012 | Issued |
Array
(
[id] => 9864693
[patent_doc_number] => 20150044712
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-02-12
[patent_title] => 'METHOD AND KIT FOR ANALYZING PROTEIN-PROTEIN INTERACTION USING NANOCLUSTER FORMATION'
[patent_app_type] => utility
[patent_app_number] => 14/234243
[patent_app_country] => US
[patent_app_date] => 2012-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 6793
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14234243
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/234243 | Method and kit for analyzing protein-protein interaction using nanocluster formation | Jul 22, 2012 | Issued |
Array
(
[id] => 8697286
[patent_doc_number] => 20130059295
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-03-07
[patent_title] => 'Host Cells and Methods for Producing Fatty Acid'
[patent_app_type] => utility
[patent_app_number] => 13/549034
[patent_app_country] => US
[patent_app_date] => 2012-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 12972
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13549034
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/549034 | Host Cells and Methods for Producing Fatty Acid | Jul 12, 2012 | Abandoned |
Array
(
[id] => 16954934
[patent_doc_number] => 11058762
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-07-13
[patent_title] => Immunogenic compositions and uses thereof
[patent_app_type] => utility
[patent_app_number] => 14/130869
[patent_app_country] => US
[patent_app_date] => 2012-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 48579
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 116
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14130869
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/130869 | Immunogenic compositions and uses thereof | Jul 5, 2012 | Issued |
Array
(
[id] => 9477169
[patent_doc_number] => 20140134632
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-15
[patent_title] => 'METHODS FOR DETERMINING DEVELOPMENTAL STAGE OF HUMAN CUMULUS CELLS'
[patent_app_type] => utility
[patent_app_number] => 14/128946
[patent_app_country] => US
[patent_app_date] => 2012-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 11309
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14128946
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/128946 | Methods for determining developmental stage of human cumulus cells | Jun 28, 2012 | Issued |
Array
(
[id] => 9656294
[patent_doc_number] => 20140227300
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-14
[patent_title] => 'INHIBITION OF INNATE IMMUNE RESPONSE'
[patent_app_type] => utility
[patent_app_number] => 14/129703
[patent_app_country] => US
[patent_app_date] => 2012-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 20636
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14129703
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/129703 | Inhibition of innate immune response | Jun 26, 2012 | Issued |
Array
(
[id] => 8854070
[patent_doc_number] => 20130143745
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-06-06
[patent_title] => 'COMPOSITIONS AND METHODS FOR IDENTIFYING THE ESSENTIAL GENOME OF AN ORGANISM'
[patent_app_type] => utility
[patent_app_number] => 13/532674
[patent_app_country] => US
[patent_app_date] => 2012-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 9411
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13532674
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/532674 | Compositions and methods for identifying the essential genome of an organism | Jun 24, 2012 | Issued |
Array
(
[id] => 12009938
[patent_doc_number] => 09803246
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-10-31
[patent_title] => 'Receptor gene for peptide cancer antigen-specific T cell'
[patent_app_type] => utility
[patent_app_number] => 14/129695
[patent_app_country] => US
[patent_app_date] => 2012-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 12263
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14129695
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/129695 | Receptor gene for peptide cancer antigen-specific T cell | Jun 19, 2012 | Issued |
Array
(
[id] => 8670971
[patent_doc_number] => 20130045508
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-02-21
[patent_title] => 'CELL EXTRACT PROMOTED CLONING'
[patent_app_type] => utility
[patent_app_number] => 13/526930
[patent_app_country] => US
[patent_app_date] => 2012-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7881
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13526930
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/526930 | Cell extract promoted cloning | Jun 18, 2012 | Issued |
Array
(
[id] => 8733090
[patent_doc_number] => 20130078658
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-03-28
[patent_title] => 'METHOD OF QUANTIFYING RECOVERY RATE OF EXOSOME'
[patent_app_type] => utility
[patent_app_number] => 13/491258
[patent_app_country] => US
[patent_app_date] => 2012-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 4468
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13491258
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/491258 | METHOD OF QUANTIFYING RECOVERY RATE OF EXOSOME | Jun 6, 2012 | Abandoned |
Array
(
[id] => 11873829
[patent_doc_number] => 09745588
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-08-29
[patent_title] => 'Transcription terminator sequences'
[patent_app_type] => utility
[patent_app_number] => 13/487083
[patent_app_country] => US
[patent_app_date] => 2012-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 9
[patent_no_of_words] => 15326
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13487083
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/487083 | Transcription terminator sequences | May 31, 2012 | Issued |
Array
(
[id] => 11790203
[patent_doc_number] => 09399779
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-07-26
[patent_title] => 'Alternative splicing constructs and methods of use'
[patent_app_type] => utility
[patent_app_number] => 13/485146
[patent_app_country] => US
[patent_app_date] => 2012-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 31
[patent_no_of_words] => 11906
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13485146
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/485146 | Alternative splicing constructs and methods of use | May 30, 2012 | Issued |
Array
(
[id] => 9597630
[patent_doc_number] => 20140194310
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-10
[patent_title] => 'GENES DYSREGULATED IN AUTISM AS BIOMARKERS AND TARGETS FOR THERAPEUTIC PATHWAYS'
[patent_app_type] => utility
[patent_app_number] => 14/119755
[patent_app_country] => US
[patent_app_date] => 2012-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 21112
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14119755
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/119755 | GENES DYSREGULATED IN AUTISM AS BIOMARKERS AND TARGETS FOR THERAPEUTIC PATHWAYS | May 23, 2012 | Abandoned |
Array
(
[id] => 9662043
[patent_doc_number] => 08809017
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-08-19
[patent_title] => 'IRES mediated multicistronic vectors'
[patent_app_type] => utility
[patent_app_number] => 13/479756
[patent_app_country] => US
[patent_app_date] => 2012-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 31
[patent_no_of_words] => 25885
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13479756
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/479756 | IRES mediated multicistronic vectors | May 23, 2012 | Issued |
Array
(
[id] => 10499822
[patent_doc_number] => 09228218
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-01-05
[patent_title] => 'Expression vector for animal cells including CSP-B 5′-SAR factor and method for producing recombinant proteins using same'
[patent_app_type] => utility
[patent_app_number] => 14/125705
[patent_app_country] => US
[patent_app_date] => 2012-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 10540
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14125705
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/125705 | Expression vector for animal cells including CSP-B 5′-SAR factor and method for producing recombinant proteins using same | May 20, 2012 | Issued |
Array
(
[id] => 12044786
[patent_doc_number] => 09822379
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-11-21
[patent_title] => 'Highly inducible dual-promoter lentiviral TET-ON system'
[patent_app_type] => utility
[patent_app_number] => 14/118880
[patent_app_country] => US
[patent_app_date] => 2012-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 13
[patent_no_of_words] => 19528
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 172
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14118880
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/118880 | Highly inducible dual-promoter lentiviral TET-ON system | May 20, 2012 | Issued |